VICTORY CAPITAL MANAGEMENT INC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 104 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
VICTORY CAPITAL MANAGEMENT INC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2023$7,293
+22.7%
10,166
-0.9%
0.00%
Q4 2022$5,945
-40.6%
10,259
-0.0%
0.00%
Q3 2022$10,000
-23.1%
10,262
-4.0%
0.00%
Q2 2022$13,000
+8.3%
10,685
-6.1%
0.00%
Q1 2022$12,000
-42.9%
11,384
-2.8%
0.00%
Q4 2021$21,000
-19.2%
11,709
-1.8%
0.00%
Q3 2021$26,000
-40.9%
11,922
-4.6%
0.00%
Q2 2021$44,000
-95.9%
12,500
-88.4%
0.00%
-100.0%
Q1 2021$1,064,000
-12.6%
107,938
-4.0%
0.00%0.0%
Q4 2020$1,218,000
-8.5%
112,387
-13.0%
0.00%
-50.0%
Q3 2020$1,331,000
-51.3%
129,171
-1.3%
0.00%
-50.0%
Q2 2020$2,733,000
-82.4%
130,870
-91.7%
0.00%
-69.2%
Q1 2020$15,492,000
+63.8%
1,585,644
+93.2%
0.01%
+18.2%
Q4 2019$9,457,000
+204.1%
820,877
+43.9%
0.01%
+175.0%
Q3 2019$3,110,000
+34.2%
570,595
+192.8%
0.00%
-20.0%
Q2 2019$2,317,000
+113.5%
194,900
-5.8%
0.01%
+150.0%
Q1 2019$1,085,000
+64.6%
207,010
-1.1%
0.00%0.0%
Q4 2018$659,000
-25.8%
209,340
+42.7%
0.00%0.0%
Q3 2018$888,000
+8.3%
146,700
-5.2%
0.00%0.0%
Q2 2018$820,000
-13.6%
154,740
-5.4%
0.00%0.0%
Q1 2018$949,000163,5800.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q3 2019
NameSharesValueWeighting ↓
BML Capital Management, LLC 3,915,000$5,872,5005.39%
Versant Venture Management, LLC 5,068,233$7,602,3504.04%
Sonic GP LLC 2,000,000$3,000,0002.91%
COMMODORE CAPITAL LP 10,000,000$15,000,0001.75%
VR Adviser, LLC 6,573,300$9,859,9501.04%
AIGH Capital Management LLC 1,323,985$1,985,9770.94%
Newtyn Management, LLC 1,025,000$1,537,5000.38%
Worth Venture Partners, LLC 331,668$497,5020.30%
Acuitas Investments, LLC 291,169$436,7540.26%
Quinn Opportunity Partners LLC 398,298$597,4470.08%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders